leonurine has been researched along with Atherogenesis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Huang, Y; Huang, YJ; Li, MY; Li, ZM; Liang, K; Lin, G; Ning, K; Wang, MJ; Yang, BF; Yu, B; Zhang, YL; Zhu, L; Zhu, YC; Zhu, YZ | 1 |
| Chen, Q; Hu, H; Jiang, T; Li, H; Lv, YC; Ren, K; Yao, R; Zhao, GJ | 1 |
| Liu, X; Wu, W; Zhu, Q; Zhu, YZ | 1 |
| Catapano, AL; Norata, GD | 1 |
| Guo, W; Liu, H; Wen, Y; Wu, J; Xiong, Q; Zhang, Y; Zhu, Y; Zou, Y | 1 |
1 review(s) available for leonurine and Atherogenesis
| Article | Year |
|---|---|
Discovery of Leonuri and therapeutical applications: From bench to bedside.
Topics: Animals; Apoptosis; Atherosclerosis; Drug Discovery; Gallic Acid; Humans; Leonurus; Medicine, Chinese Traditional; Neurodegenerative Diseases | 2018 |
4 other study(ies) available for leonurine and Atherogenesis
| Article | Year |
|---|---|
eNOS-Nitric Oxide System Contributes to a Novel Antiatherogenic Effect of Leonurine via Inflammation Inhibition and Plaque Stabilization.
Topics: Animals; Atherosclerosis; Cell Line; Gallic Acid; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type III; Plaque, Atherosclerotic; Signal Transduction | 2020 |
Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner.
Topics: Animals; Antioxidants; Aorta; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Cell Line; Cholesterol; Gallic Acid; Humans; Leonurus; Lipid Metabolism; Liver X Receptors; Male; Mice; PPAR gamma; Signal Transduction; Up-Regulation | 2017 |
Leonurine: a new comer in the natural compounds affecting atherosclerosis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Atherosclerosis; Gallic Acid; Male | 2012 |
SCM-198 attenuates early atherosclerotic lesions in hypercholesterolemic rabbits via modulation of the inflammatory and oxidative stress pathways.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Atherosclerosis; Chemokine CCL2; Gallic Acid; Hypercholesterolemia; Intercellular Adhesion Molecule-1; Interleukin-6; Lipid Peroxidation; Lipids; Male; Rabbits; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2012 |